Humana Target Price

Where could HUM trade next? Consensus target price: $350.

Get informed when a big investor buys or sells

+ Follow

Share Price

$384.97

Average Target Price

$349.18

9.3% downside

33 analysts in the last 4 months

High: $513 | Low: $180

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-04	Morgan Stanley	$370	3.9% downside
2026-07-31	Barclays	$407	5.7% upside
2026-07-30	Robert W. Baird	$390	1.3% upside
2026-07-30	OppenheimerMichael Wiederhorn	$405	5.2% upside
2026-07-30	Leerink Partners	$513	33.3% upside
2026-07-30	Guggenheim	$471	22.3% upside
2026-07-30	Piper Sandler	$463	20.3% upside
2026-07-30	UBS	$405	5.2% upside
2026-07-29	Evercore ISI	$480	24.7% upside
2026-07-20	Jefferies	$410	6.5% upside
2026-07-14	Truist FinancialDavid MacDonald	$415	7.8% upside
2026-07-13	Wells FargoStephen Baxter	$502	30.4% upside
2026-07-09	RBC Capital	$415	7.8% upside
2026-07-07	Raymond JamesSarah James	$300	22.1% downside
2026-07-07	Cantor Fitzgerald	$300	22.1% downside
2026-06-08	Mizuho Securities	$390	1.3% upside
2026-06-04	Morgan Stanley	$249	35.3% downside
2026-06-03	Bernstein	$425	10.4% upside
2026-06-01	Truist FinancialDavid MacDonald	$320	16.9% downside
2026-05-26	Barclays	$344	10.6% downside
2026-05-22	UBS	$320	16.9% downside
2026-05-20	Mizuho Securities	$335	13% downside
2026-05-20	Deutsche Bank	$441	14.6% upside
2026-05-15	Morgan StanleyErin Wright	$217	43.6% downside
2026-05-13	Piper Sandler	$254	34% downside
2026-05-01	Raymond James	$260	32.5% downside
2026-04-30	Truist FinancialDavid MacDonald	$270	29.9% downside
2026-04-30	Oppenheimer	$260	32.5% downside
2026-04-30	Deutsche Bank	$235	39% downside
2026-04-30	Guggenheim	$269	30.1% downside
2026-04-30	RBC CapitalBen Hendrix	$246	36.1% downside
2026-04-30	Barclays	$180	53.2% downside
2026-04-30	UBS	$262	31.9% downside
2026-04-08	Evercore ISI	$195	49.3% downside
2026-04-08	Mizuho Securities	$258	33% downside
2026-02-18	Wells Fargo	$206	46.5% downside
2026-02-17	Truist Financial	$200	48% downside
2026-02-13	Deutsche BankGeorge Hill	$180	53.2% downside
2026-02-12	Raymond JamesSarah James	$201	47.8% downside
2026-02-12	RBC CapitalBen Hendrix	$189	50.9% downside
2026-02-12	UBS	$195	49.3% downside
2026-02-12	Guggenheim	$252	34.5% downside
2026-02-12	Morgan Stanley	$146	62.1% downside
2026-02-12	Oppenheimer	$250	35.1% downside
2026-02-02	Morgan Stanley	$174	54.8% downside
2026-01-07	Wells Fargo	$290	24.7% downside
2026-01-06	Bernstein	$344	10.6% downside
2025-12-18	Morgan StanleyErin Wright	$262	31.9% downside
2025-12-05	JefferiesDavid Windley	$313	18.7% downside
2025-11-25	BarclaysAndrew Mok	$234	39.2% downside

Humana (HUM) FAQ

Humana (HUM) currently reports a target price of $350. Use the charts on this page to explore Humana's target price history and peer comparisons.

Analysts' average 12-month price target for Humana is $350, about 9.3% downside from the current share price of $384.97. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $350, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Humana, and consider following HUM for alerts when major investors trade the stock.

Humana is classified in the Healthcare sector. On target price, it currently shows $350. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HUM with unrelated industries.